Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.

Saved in:
Bibliographic Details
Title: Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.
Authors: Cooley LS; University of Bordeaux, LAMC, Pessac, France.; INSERM U1029, Pessac, France., Rudewicz J; University of Bordeaux, LAMC, Pessac, France.; INSERM U1029, Pessac, France.; Bordeaux Bioinformatics Center, CBiB, University of Bordeaux, Bordeaux, France., Souleyreau W; University of Bordeaux, LAMC, Pessac, France.; INSERM U1029, Pessac, France., Emanuelli A; University of Bordeaux, LAMC, Pessac, France.; INSERM U1029, Pessac, France., Alvarez-Arenas A; Mathematical Modeling for Oncology Team, Inria Bordeaux Sud-Ouest, Talence, France.; Department of Mathematics, Mathematical Oncology Laboratory (MOLAB), Universidad de Castilla-La Mancha, Ciudad Real, Spain., Clarke K; University of Liverpool, Institute of Systems, Molecular and Integrative Biology, Liverpool, UK., Falciani F; University of Liverpool, Institute of Systems, Molecular and Integrative Biology, Liverpool, UK., Dufies M; Centre Scientifique de Monaco, Biomedical Department, Principality of Monaco, Monaco.; University Côte d'Azur, Institute for Research on Cancer and Aging of Nice (IRCAN), CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, Nice, France., Lambrechts D; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium., Modave E; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium., Chalopin-Fillot D; Bordeaux Bioinformatics Center, CBiB, University of Bordeaux, Bordeaux, France.; University of Bordeaux, IBGC, Bordeaux, France., Pineau R; University of Bordeaux, 'Service Commun des Animaleries', Bordeaux, France., Ambrosetti D; Centre Hospitalier Universitaire (CHU) de Nice, Hôpital Pasteur, Central laboratory of Pathology, Nice, France., Bernhard JC; Centre Hospitalier Universitaire (CHU) de Bordeaux, service d'urologie, Bordeaux, France., Ravaud A; Centre Hospitalier Universitaire (CHU) de Bordeaux, service d'oncologie médicale, Bordeaux, France., Négrier S; Université de Lyon, Centre Léon Bérard, Lyon, France., Ferrero JM; Centre Antoine Lacassagne, Clinical Research Department, Nice, France., Pagès G; Centre Scientifique de Monaco, Biomedical Department, Principality of Monaco, Monaco.; University Côte d'Azur, Institute for Research on Cancer and Aging of Nice (IRCAN), CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, Nice, France., Benzekry S; Mathematical Modeling for Oncology Team, Inria Bordeaux Sud-Ouest, Talence, France.; COMPO team-project, Inria Sophia Antipolis and CRCM, Inserm U1068, CNRS UMR7258, Aix-Marseille University UM105, Institut Paoli-Calmettes, Marseille, France., Nikolski M; Bordeaux Bioinformatics Center, CBiB, University of Bordeaux, Bordeaux, France.; University of Bordeaux, IBGC, Bordeaux, France., Bikfalvi A; University of Bordeaux, LAMC, Pessac, France. andreas.bikfalvi@u-bordeaux.fr.; INSERM U1029, Pessac, France. andreas.bikfalvi@u-bordeaux.fr.
Source: Molecular cancer [Mol Cancer] 2021 Oct 20; Vol. 20 (1), pp. 136. Date of Electronic Publication: 2021 Oct 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-4598
DOI:10.1186/s12943-021-01416-5